Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Becton Dickinson and Co (BDX) vs Lucid Group Inc (LCID) Price & Performance

Becton Dickinson and CoTrade
Lucid Group IncTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Lucid Group Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Lucid Group Inc trades at $6.69 (market cap $2.60B). The key difference: Becton Dickinson and Co is far larger — about 18.8× Lucid Group Inc's market cap, and Becton Dickinson and Co pays a 2.34% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals.

BDXLCID
Market Cap
$48.93B$2.60B
Sector
HealthConsumer Cyclical
52-Week High
$185.39$24.77
52-Week Low
$138.62$4.62
Enterprise Value
$65.03B$5.50B
Dividend Yield
2.34%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.

The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.

Lucid Group Inc

Lucid Group (LCID) trades at $7.04, up 0.86% with a neutral technical signal despite recent earnings misses. The company reported Q2 2026 revenue of $405.3 million (beating estimates) but a wider loss of $3.30 per share due to inventory charges. Management is executing a $1.4 billion operational reset focusing on cost reductions, robotaxi partnerships, and delaying the Cosmos EV launch to 2027. Financial metrics show severe challenges with negative gross margins of -96.56% and net income margin of -249.21%.

The outlook remains high-risk with persistent cash burn and competitive pressures, though analyst consensus targets $10.50 representing 49% upside. Key risks include execution of the turnaround plan, EV market demand, and the need for future capital raises. The stock offers speculative potential if cost savings materialize but faces significant fundamental headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX

About Lucid Group Inc

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.

Read more on LCID